Cargando…

Anticoagulation in COVID-19: reaction to the ACTION trial

Detalles Bibliográficos
Autores principales:	Berger, Jeffrey S, Connors, Jean Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192086/ https://www.ncbi.nlm.nih.gov/pubmed/34119049 http://dx.doi.org/10.1016/S0140-6736(21)01291-5

Ejemplares similares

Anticoagulation in COVID-19
por: Bradbury, Charlotte A, et al.
Publicado: (2022)

Antithrombotic prophylaxis for symptomatic outpatients with COVID-19: less is consistently more
por: Connors, Jean M, et al.
Publicado: (2022)

COVID-19 vaccine hesitancy in Africa: a call to action
por: Mutombo, Polydor Ngoy, et al.
Publicado: (2022)

India's resurgence of COVID-19: urgent actions needed
por: Aiyar, Yamini, et al.
Publicado: (2021)

The course of action for effective anti-cytokine treatment in COVID-19
por: Cavalli, Giulio, et al.
Publicado: (2021)

India's COVID-19 crisis: a call for international action
por: Kuppalli, Krutika, et al.
Publicado: (2021)

The necessity for intra-action reviews during the COVID-19 pandemic
por: Mayigane, Landry Ndriko, et al.
Publicado: (2020)

COVID-19 and mass incarceration: a call for urgent action
por: Macmadu, Alexandria, et al.
Publicado: (2020)

Vaccinate fast but leave no one behind: a call to action for COVID-19 vaccination in Spain
por: Lazarus, Jeffrey V., et al.
Publicado: (2021)

EU guidance impedes humanitarian action to prevent COVID-19 in Syria
por: Hussain, Hamid Yahiya, et al.
Publicado: (2020)

COVID-19 impact on early career investigators: a call for action
por: Levine, Ross L., et al.
Publicado: (2020)

A call for action for COVID-19 surveillance and research during pregnancy
por: Buekens, Pierre, et al.
Publicado: (2020)

Racial and ethnic differences in COVID-19 outcomes: a call to action
por: Robinson, Philip C, et al.
Publicado: (2022)

When to use anticoagulation in COVID-19()()
por: Moll, Matthew, et al.
Publicado: (2021)

α1-Antitrypsin deficiency and the risk of COVID-19: an urgent call to action
por: Yang, Chengliang, et al.
Publicado: (2021)

Obesity and COVID-19: a call for action from people living with obesity
por: Le Brocq, S, et al.
Publicado: (2020)

Men's health: COVID-19 pandemic highlights need for overdue policy action
por: Baker, Peter, et al.
Publicado: (2020)

Take action to mitigate the impact of the COVID-19 pandemic on HIV prevention and control
por: Yan, Xiangyu, et al.
Publicado: (2023)

Urgent actions and policies needed to address COVID-19 among UK ethnic minorities
por: Mathur, Rohini, et al.
Publicado: (2020)

COVID-19 and its implications for thrombosis and anticoagulation
por: Connors, Jean M., et al.
Publicado: (2020)

A call to action: A need for initiatives that increase equitable access to COVID-19 therapeutics
por: Abdul-Mutakabbir, Jacinda C., et al.
Publicado: (2022)

COVID-19, community trials, and inclusion
por: Gill, Paramjit S, et al.
Publicado: (2021)

A call for immediate action to increase COVID-19 vaccination uptake to prepare for the third pandemic winter
por: Betsch, Cornelia, et al.
Publicado: (2022)

Rethinking cancer clinical trials for COVID-19 and beyond
por: Doherty, Gary J., et al.
Publicado: (2020)

COVID-19: ACT trials for colchicine and antithrombotic therapies
por: Barco, Stefano, et al.
Publicado: (2022)

Stewardship of COVID-19 volunteers by nested trial design
por: Gottlieb, Robert L, et al.
Publicado: (2022)

PIONEER trial: favipiravir to treat moderate COVID-19
por: Shalhoub, Sarah
Publicado: (2023)

Call for action: Health services in the European region must adopt integrated care models to manage Post-Covid-19 Condition
por: Kluge, Hans Henri P., et al.
Publicado: (2022)

Mitigating the impacts of COVID-19: where are the mental health trials?
por: Gilbody, Simon, et al.
Publicado: (2021)

PRINCIPLE: a community-based COVID-19 platform trial
por: Macleod, John, et al.
Publicado: (2021)

The COVID-19 pandemic: a catalyst to improve clinical trials
por: Gaba, Prakriti, et al.
Publicado: (2020)

COVID-19 vaccine trials should seek worthwhile efficacy
por: Krause, Philip, et al.
Publicado: (2020)

US COVID-19 clinical trial leadership gender disparities
por: Sehgal, Neil K R, et al.
Publicado: (2023)

Children, adolescent, and youth mental health in Sri Lanka in the context of recent violence, COVID-19, and economic crisis: A call for action
por: Shoib, Sheikh, et al.
Publicado: (2022)

Clinical trials of disease stages in COVID 19: complicated and often misinterpreted
por: Park, Jay J H, et al.
Publicado: (2020)

COVID-19 vaccines: breaking record times to first-in-human trials
por: Kim, Young Chan, et al.
Publicado: (2020)

Haemoperfusion should only be used for COVID-19 in the context of randomized trials
por: Clark, Edward G., et al.
Publicado: (2020)

Challenges in operationalising clinical trials in India during the COVID-19 pandemic
por: Bassi, Abhinav, et al.
Publicado: (2022)

Maintaining confidentiality of emerging results in COVID-19 vaccine trials is essential
por: Krause, Philip R, et al.
Publicado: (2020)

The Lancet COVID-19 Commission
por: Sachs, Jeffrey D, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4k300m727unuv4890l39aook34